Clinical Trial Update: Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.

View source ↗

Summary

A multi-site retrospective chart review assessing real-world effectiveness of afatinib following immunotherapy in patients with metastatic squamous cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Gilotrif (Afatinib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Non-squamous, Non-Small Cell Lung Cancer | Status: COMPLETED | Results posted: 2024-09-19